Oncolytics Biotech Inc.
Records under this name other than the patents Oncolytics Biotech Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 11 patents it holds.
Back to Oncolytics Biotech Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,685,734 | Viral purification methods Lapsed on the fee record Ended Apr 1, 2026 · From the USPTO record | Lapsed on the fee record | Ended Apr 1, 2026 | From the USPTO record |
| US 10,167,452 | Viral Purification Methods Term ended Ended no later than Dec 12, 2025 · Low confidence | Term ended | Ended no later than Dec 12, 2025 | Low confidence |
| US 7,815,914 | Methods for the Treatment of Cellular Proliferative Disorders Term ended Term ended Jan 4, 2025 · High confidence | Term ended | Term ended Jan 4, 2025 | High confidence |
| US 7,344,711 | Use of adenoviruses mutated in the VA genes for cancer treatment Term ended Term ended Mar 5, 2024 · From the USPTO record | Term ended | Term ended Mar 5, 2024 | From the USPTO record |
| US 8,298,785 | Use of ribozymes in the detection of adventitious agents Term ended Term ended Jan 25, 2024 · From the USPTO record | Term ended | Term ended Jan 25, 2024 | From the USPTO record |
| US 7,198,783 | Sensitization of neoplastic cells to radiation therapy with reovirus Term ended Term ended Dec 10, 2023 · From the USPTO record | Term ended | Term ended Dec 10, 2023 | From the USPTO record |
| US 7,306,902 | Oncolytic viruses as phenotyping agents for neoplasms Term ended Term ended Dec 8, 2023 · From the USPTO record | Term ended | Term ended Dec 8, 2023 | From the USPTO record |
| US 7,163,678 | Reovirus for the treatment of ral-mediated cellular proliferative disorders Term ended Term ended Nov 6, 2023 · From the USPTO record | Term ended | Term ended Nov 6, 2023 | From the USPTO record |
| US 7,223,585 | Viral purification methods Term ended Term ended Oct 15, 2023 · From the USPTO record | Term ended | Term ended Oct 15, 2023 | From the USPTO record |
| US 7,052,832 | Methods for the Treatment of Cellular Proliferative Disorders Term ended Term ended Apr 4, 2023 · High confidence | Term ended | Term ended Apr 4, 2023 | High confidence |